FDA Strips Breast Cancer Warning from Menopause Hormone Therapy
NeutralArtificial Intelligence
The Food and Drug Administration (FDA) has reversed its previous stance by removing black box warnings from hormone replacement therapies used for menopause. This decision marks a significant change in the regulatory landscape for these treatments, which have been under scrutiny for potential health risks, including breast cancer.
— via World Pulse Now AI Editorial System